Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpePharm
Amsterdam, North Holland, Netherlandsspepharm.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Other
01
Overview
SpePharm has commercialized specialty medications for European hospital markets, focusing on niche and orphan indications predominantly in oncology and hematology, such as Savene (dexrazoxane) for anthracycline extravasation. No recent clinical trial results are disclosed; the company acquires existing products rather than developing them de novo.
- Therapeutic areas
- OncologyGastroenterologyOtherHematology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
BioAlliance Pharma (SpeBio JV)TopoTarget (Savene acquisition)
Beyond the preview
Go deeper on SpePharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SpePharm.